Goldman says to buy Carter's ahead of margin inflection Goldman said there has been a positive inflection in live births in the U.S. for the first time since 2007 and said Carter's is the most leveraged to improving birth trends. The analyst recommends buying Carter's ahead of strong organic growth and margin improvement. Shares are Buy rated with a $102 price target.
Carter's reports Q2 Carter's Retail sales up 5.7% to $247M Reports Q2 Carter's Wholesale sales up 5.8% to $211.7M. Reports Q2 OshKosh Retail sales up 8.8% to $73.5M. Reports OshKosh Wholesale sales up 22.8% to $14.3M. Reports Q2 International sales up 8.4% to $66.3M.